Submission Details
| 510(k) Number | K220311 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | February 02, 2022 |
| Decision Date | May 03, 2022 |
| Days to Decision | 90 days |
| Submission Type | Traditional |
| Review Panel | Radiology (RA) |
| Summary | Summary PDF |
K220311 is an FDA 510(k) clearance for the Cardiovascular Angiography System, a Interventional Fluoroscopic X-ray System (Class II — Special Controls, product code OWB), submitted by Allengers Medical Systems Limited (Derabassi, Distt. Mohali, IN). The FDA issued a Cleared decision on May 3, 2022, 90 days after receiving the submission on February 2, 2022. This device falls under the Radiology review panel. Regulated under 21 CFR 892.1650.
| 510(k) Number | K220311 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | February 02, 2022 |
| Decision Date | May 03, 2022 |
| Days to Decision | 90 days |
| Submission Type | Traditional |
| Review Panel | Radiology (RA) |
| Summary | Summary PDF |
| Product Code | OWB — Interventional Fluoroscopic X-ray System |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 892.1650 |
| Definition | Interventional Fluoroscopy |